A combination of two drugs showed promising phase 2 results, including a reduction in cognitive impairment in patients with lacunar stroke, and may be a potential new approach to small vessel disease.
When Katie Mulligan baked a beetroot cake for her colleagues at a London advertising agency, she was focused on getting the recipe right rather than whether it was acceptable to bring treats into the office.
Genetic makeup is the key driver for the increased risk of gout found in families with a history of the disease. This risk is increased in people who are also heavy drinkers or have overweight/obesity.
Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized lifestyle and weight reduction programs, announces initial results from patient studies of its metabolic health program Miboko with the National Health Service (NHS) in the United Kingdom.